Korean Circulation Journal

  • 제42권7호
  • /
  • Pages.464-470
  • /
  • 2012
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Serial Plasma Levels of Angiogenic Factors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  • Kim, Bo-Hyun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Ko, Young-Guk (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Her, Ae-Young (Division of Cardiology, Kangwon National University Hospital) ;
  • Kim, Jung-Sun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Hwang, Ki-Chul (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shin, Dong-Ho (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kim, Byeong-Keuk (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Choi, Dong-Hoon (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Ha, Jong-Won (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Hong, Myeong-Ki (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Jang, Yang-Soo (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System)
  • 발행 : 2012.07.31
⟨ 이전 논문 다음 논문 ⟩

초록

Background and Objectives: Patients with acute myocardial infarction show varying degrees of collateral development. However, the relationships between angiogenic factors and degree of collaterals are not well known. Subjects and Methods: Fifty-nine patients (mean age, 59${\pm}$10 years) with ST-segment elevation myocardial infarction (STEMI) underwent primary percutaneous coronary intervention (PCI). Patients were divided into one of 2 groups: group I (Rentrop collateral grade 0/1, n=34) or group II (grade 2/3, n=25). Plasma levels of vascular endothelial growth factor (VEGF), soluble VEGF receptor (sFlt-1), angiopoietin (Ang)-2, and soluble Tie-2 at baseline, 24 and 48 hours after PCI were measured. Results: There were fewer diabetic patients and higher incidence of previous angina and multi-vessel disease in group II. Group II had a lower left ventricular ejection fraction and a trend toward longer pain-to-balloon time. Plasma levels of Ang-2, sFlt-1 were elevated prior to primary PCI and decreased after PCI, whereas plasma level of VEGF was relatively low initially, however rose after PCI. sTie-2 levels showed no significant interval change in group I, but decreased over time in group II. VEGF, sFlt-1, and Tie-2 levels did not differ between the groups at each time point. However, plasma levels of Ang-2 were higher in group I than in group II at baseline and at 48 hours. Conclusion: Presence of collaterals in STEMI patients undergoing primary PCI was associated with lesser rise in Ang-2 plasma level. VEGF showed a delayed response to acute ischemia compared to Ang-2. Clinical implications of our findings need to be investigated in further studies.

키워드

참고문헌

  1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95. https://doi.org/10.1038/74651
  2. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611. https://doi.org/10.1210/er.2003-0027
  3. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 2006;10:515-27. https://doi.org/10.1007/s11030-006-9027-3
  4. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003-12. https://doi.org/10.1016/j.cellsig.2007.05.013
  5. Thomas M, Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 2009;12:125-37. https://doi.org/10.1007/s10456-009-9147-3
  6. Tressel SL, Kim H, Ni CW, et al. Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol 2008;28:1989-95. https://doi.org/10.1161/ATVBAHA.108.175463
  7. Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM. Expression of VEGF and angiopoietins-1 and -2 during ischemiainduced coronary angiogenesis. Am J Physiol Heart Circ Physiol 2003;285:H352-8.
  8. Saharinen P, Bry M, Alitalo K. How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 2010;17:198-205.
  9. Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 2007;27:2619-26. https://doi.org/10.1161/ATVBAHA.107.150482
  10. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324-8. https://doi.org/10.1006/bbrc.1996.1355
  11. Siemeister G, Schirner M, Weindel K, et al. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res 1999;59:3185-91.
  12. Elsman P, van't Hof AW, de Boer MJ, et al. Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J 2004;25:854-8. https://doi.org/10.1016/j.ehj.2004.03.005
  13. Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 2003;10:83-97. https://doi.org/10.1080/mic.10.1.83.97
  14. Berry C, Balachandran KP, L'Allier PL, Lespérance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J 2007;28:278-91. https://doi.org/10.1093/eurheartj/ehl446
  15. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92. https://doi.org/10.1016/S0735-1097(85)80380-6
  16. Van Royen N, Piek JJ, Schaper W, Fulton WF. A critical review of clinical arteriogenesis research. J Am Coll Cardiol 2009;55:17-25. https://doi.org/10.1016/j.jacc.2009.06.058
  17. Rentrop KP, Thornton JC, Feit F, Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 1988;61:677-84. https://doi.org/10.1016/0002-9149(88)91048-X
  18. Beygui F, Le Feuvre C, Helft G, Maunoury C, Metzger JP. Myocardial viability, coronary flow reserve, and in-hospital predictors of late recovery of contractility following successful primary stenting for acute myocardial infarction. Heart 2003;89:179-83. https://doi.org/10.1136/heart.89.2.179
  19. Ogawa H, Suefuji H, Soejima H, et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000;93:93-9. https://doi.org/10.1159/000007008
  20. Iribarren C, Phelps BH, Darbinian JA, et al. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord 2011;11:31. https://doi.org/10.1186/1471-2261-11-31
  21. Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000;35:968-73. https://doi.org/10.1016/S0735-1097(99)00632-4
  22. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004;110:2355-60. https://doi.org/10.1161/01.CIR.0000138112.90641.7F
  23. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-33. https://doi.org/10.1056/NEJM200003023420904
  24. Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A 2002;99:8219-24. https://doi.org/10.1073/pnas.122109599
  25. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 2002;99:11205-10. https://doi.org/10.1073/pnas.172161899

피인용 문헌

  1. Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention vol.2014, pp.None, 2014, https://doi.org/10.1155/2014/135357